By Abigail Townsend
Date: Wednesday 01 May 2024
(Sharecast News) - Pfizer raised its full-year earnings forecast on Wednesday, on the back of solid demand for its non-Covid products.
Patent Woes Threaten Drug Firms | 07-Mar-2011 | New York Times |
Stocks push higher on deals and strong earnings | 09-Feb-2011 | USA Today |
Dow soars to close above 12,000 | 02-Feb-2011 | Wall Street Journal |
Pfizer To Close UK Plant And Axe 2,400 Jobs | 01-Feb-2011 | Sky News |
Despite good earnings reports, stocks tumble | 21-Oct-2009 | Wall Street Journal |
Currency | US Dollars |
Share Price | $ 27.42 |
Change Today | $ -0.57 |
% Change | -2.04 % |
52 Week High | $37.51 |
52 Week Low | $25.26 |
Volume | 30,210,522 |
Shares Issued | 5,646m |
Market Cap | $154,813m |
RiskGrade | 102 |
Strong Buy | 3 |
Buy | 6 |
Neutral | 15 |
Sell | 0 |
Strong Sell | 0 |
Total | 24 |
Time | Volume / Share Price |
16:00 | 4,047,779 @ $27.42 |
15:59 | 269 @ $27.42 |
15:59 | 300 @ $27.42 |
15:59 | 100 @ $27.42 |
15:59 | 100 @ $27.42 |
You are here: research